Yuji Aoki (2016) “Comparison of Diuretic Effects between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics”, Diabetes Research, 2(2), pp. 45–49. Available at: https://openventio.us/index.php/DR/article/view/1621 (Accessed: 29 July 2026).